Medicine and device developers continue to focus on patient safety long after receiving market approval. This post-marketing phase is a critical stage for pharmacovigilance, offering insight into ...

The recent collapse of the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) negotiations has added more uncertainty and complexity to a UK healthcare system already undergoing ...